NIH Human Embryonic Stem Cell Registry - Cell Lines Not Approved for NIH Funding Eligibility
U.S. Department of Health & Human Services Logo
NIH > Office of Extramural Research Logo
Home About Grants Funding Forms & Deadlines Grants Policy News & Events About OER NIH Home
Grants and Funding

NIH Human Embryonic Stem Cell Registry
Cell Lines Not Approved for NIH Funding Eligibility

The following is a list of list human embryonic stem cell line(s) not approved for use in NIH funded research.

Line(s) Not Approved:  66
Date/Time: 		(in 12 Submissions)
02/16/2013 at 10:52 AM
Cell Line Name Organization
HUES25 Harvard University
RG-148; DYSTROPHIA MYOTONICA 1 (DM1), affected, 46,XY Reproductive Genetics Institute
RG-153; DYSTROPHIA MYOTONICA 1 (DM1), affected, 46,XX Reproductive Genetics Institute
RG-170; MUSCULAR DYSTROPHY, BECKER TYPE (BMD), affected, 46,XY Reproductive Genetics Institute
RG-186; HUNTINGTON DISEASE (HD), affected, 46,XX Reproductive Genetics Institute
RG-194; HUNTINGTON DISEASE (HD), affected, 46,XY Reproductive Genetics Institute
RG-233; HEMOGLOBIN BETA LOCUS (HBB), affected (HbS/HbS - sickle cell anemia), 46,XX Reproductive Genetics Institute
RG-245; EMERY-DREIFUSS MUSCULAR DYSTROPHY, X-LINKED (EDMD), carrier, 47,XXY Reproductive Genetics Institute
RG-246; EMERY-DREIFUSS MUSCULAR DYSTROPHY, X-LINKED (EDMD), affected, 46,XY Reproductive Genetics Institute
RG-271; TORSION DYSTONIA 1 ( DYT1), AUTOSOMAL DOMINANT, affected (N/GAG del), 46,XY Reproductive Genetics Institute
RG-283; MUSCULAR DYSTROPHY, DUCHENNE TYPE (DMD), affected, 46,XY Reproductive Genetics Institute
RG-288; CYSTIC FIBROSIS (CF), affected (deltaF508/deltaF508), 46,XY Reproductive Genetics Institute
RG-289; CYSTIC FIBROSIS (CF), affected (deltaF508/deltaF508), 46,XX Reproductive Genetics Institute
RG-301; MUSCULAR DYSTROPHY, DUCHENNE TYPE( DMD) affected, 46,XY Reproductive Genetics Institute
RG-302; MUSCULAR DYSTROPHY, DUCHENNE TYPE (DMD), carrier, 46,XX Reproductive Genetics Institute
RG-315; NEUROFIBROMATOSIS, TYPE I (NF1), affected (R19 47X/N), 46,XY Reproductive Genetics Institute
RG-316; TUBEROUS SCLEROSIS, TYPE 1(TSC1), affected (N/IVS7+1 G-A) Reproductive Genetics Institute
RG-320; TUBEROUS SCLEROSIS, TYPE 1(TSC1), affected (N/IVS7+1 G-A) Reproductive Genetics Institute
RG-326; POPLITEAL PTERYGIUM SYNDROME (PPS),affected (R84H/N), 46,XY Reproductive Genetics Institute
RG-328; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1A( FSHD), affected, 46,XY Reproductive Genetics Institute
RG-330; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1A (FSHD), affected, 46,XY Reproductive Genetics Institute
RG-333; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1A (FSHD), affected, 46,XX Reproductive Genetics Institute
RG-356; HEMOGLOBIN ALPHA LOCUS (HBA), affected (-alpha /--), 46,XX Reproductive Genetics Institute
RG-357; EMERY-DREIFUSS MUSCULAR DYSTROPHY, X-LINKED (EDMD), affected, 46,XY Reproductive Genetics Institute
RG-358; EMERY-DREIFUSS MUSCULAR DYSTROPHY, X-LINKED (EDMD), affected, 46,XY Reproductive Genetics Institute
RG-401; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1A (FSHD), affected, 46,XX Reproductive Genetics Institute
RG-402; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1A (FSHD), affected, 46,XX Reproductive Genetics Institute
RG-403; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1A (FSHD), affected Reproductive Genetics Institute
RG-404; SPINAL MUSCULAR ATROPHY, TYPE I (SMA1), affected, 46,XY Reproductive Genetics Institute
RG-406; TORSION DYSTONIA 1, AUTOSOMAL DOMINANT (DYT1), affected (N/GAG del) Reproductive Genetics Institute
RG-413; BREAST CANCER, FAMILIAL (BRCA2),affected (N/IVS7 GT del) & MULTIPLE ENDOCRINE NEOPLASIA, TYPE I (MEN1), affected (N/3036 4bp del) Reproductive Genetics Institute
RG-414; MULTIPLE ENDOCRINE NEOPLASIA, TYPE I ( MEN1), affected (N/3036 4bp del) Reproductive Genetics Institute
RG-415; HUNTINGTON DISEASE (HD), affected Reproductive Genetics Institute
RG-416; CYSTIC FIBROSIS (CF), affected (deltaF508/1717-1 G-A) Reproductive Genetics Institute
RG-417; CYSTIC FIBROSIS (CF), affected (deltaF508/1717-1 G-A) Reproductive Genetics Institute
RG-418; HEMOGLOBIN BETA LOCUS (HBB), affected (cd8+G /619del) Reproductive Genetics Institute
RG-420; HEMOGLOBIN BETA LOCUS (HBB), affected (cd8+G/619del) Reproductive Genetics Institute
RG-422; CYSTIC FIBROSIS (CF), affected (N1303K/deltaF508) Reproductive Genetics Institute
RG-423; CYSTIC FIBROSIS (CF), carrier (N/deltaF508) Reproductive Genetics Institute
RG-424; MULTIPLE ENDOCRINE NEOPLASIA, TYPE 2 (MEN2B), affected (M918T/N) Reproductive Genetics Institute
RG-426; PELIZAEUS-MERZBACHER DISEASE (PMLD), affected Reproductive Genetics Institute
RG-428; TUBEROUS SCLEROSIS, TYPE 1 (TSC1), affected (N/IVS7+1 G-A) Reproductive Genetics Institute
RG-222 Reproductive Genetics Institute
RG-230 Reproductive Genetics Institute
RG-249 Reproductive Genetics Institute
RG-308 Reproductive Genetics Institute
RG-313 Reproductive Genetics Institute
RG-399; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1A (FSHD), affected, 46,XX Reproductive Genetics Institute
RNJ7 Reprogenetics, LLC
CM-2 Children's Memorial Hospital
CM-6 Children's Memorial Hospital
CM-7 Children's Memorial Hospital
FY-hES-1 THE THIRD AFFILIATED HOSPITAL OF GUANGZHOU MEDICAL COLLEGE
FY-hES-3 THE THIRD AFFILIATED HOSPITAL OF GUANGZHOU MEDICAL COLLEGE
FY-hES-5 THE THIRD AFFILIATED HOSPITAL OF GUANGZHOU MEDICAL COLLEGE
FY-hES-7 THE THIRD AFFILIATED HOSPITAL OF GUANGZHOU MEDICAL COLLEGE
FY-hES-8 THE THIRD AFFILIATED HOSPITAL OF GUANGZHOU MEDICAL COLLEGE
FY-3PN THE THIRD AFFILIATED HOSPITAL OF GUANGZHOU MEDICAL COLLEGE
CR1 The University of Texas Health Science Center at Houston
CR2 The University of Texas Health Science Center at Houston
K117 VistaGen Therapeutics, Inc.
J618 VistaGen Therapeutics, Inc.
J713 VistaGen Therapeutics, Inc.
RNJ11 Reprogenetics, LLC
RNJ12 Reprogenetics, LLC
CSC14 (not approved) California Stem Cell, Inc.


Go to NIH Form 2890 Login Page

Go to NIH Stem Cell Information Page


   
Related Resources

    NIH Form 2890:

  • Login Page
    (Authorization Required)
    Contact Us:

  • Email questions to:
    hescregistry@mail.nih.gov

    • (Emails that are offensive or unrelated to stem cells will be deleted.)
 

This page last updated on July 13, 2011
Content Manager: stemcell@mail.nih.gov
Technical Issues: E-mail OER Webmaster

Social Media Links